Pacific Bio (PACB) Q3 Revenue Misses Estimates

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of $0.02, may not compare to the analyst estimate of ($0.27). Revenue for the quarter came in at $13.9 million versus the consensus estimate of $15.84 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• After-Hours Stock Movers: FDX, CBRS, NKE